Information Hub
Access guidance, webcasts and publications with commentaries using the ABS Information Hub. Search by classification or using keywords.
To view the webcasts from previous ABS Conferences, events and webinars you must be an ABS member and be logged in using your membership username and password.
-
menu_book
Duration of adjuvant aromatase-inhibitor therapy in postmenopausal breast cancer
This prospective randomised trial assigned postmenopausal women with HR-positive breast cancer who had received 5 years of adjuvant endocrine therapy (n=3484) to receive either additional 2 or 5 years...
Michael Gnant et al | The New England Journal of Medicine
28.07.2021 | Added: 28.07.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Endocrine Therapy
menu_bookPublication menu_book -
menu_book
Adjuvant Olaparib for Patients with BRCA1- or BRCA2-Mutated Breast Cancer
Andrew N.J Tutt et al | The New England Journal of Medicine
03.06.2021 | Added: 03.06.2021
Classifications: Adjuvant & Neoadjuvant Treatment
Keywords: Adjuvant treatment BRCA
menu_bookPublication menu_book -
menu_book
A Randomized, Controlled Trial of Cavity Shave Margins in Breast Cancer
Shave margins reducer re-excision rate by 50% but increase volume of excised tissue
Anees B Chagpar et al | The New England Journal of Medicine
06.08.2015 | Added: 06.08.2015
Classifications: Breast & Oncoplastic Surgery
Keywords: Surgical margins Trials
menu_bookPublication menu_book
